Redcare Pharmacy NV (XSWX:RDC) Buyback Yield %: -0.01 (As of Jun. 27, 2026)


XSWX:RDC Redcare Pharmacy NV XSWX:RDC
48 GF Score
Price CHF60.95
GF Value CHF143.20
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Redcare Pharmacy NV Buyback Yield %?

Redcare Pharmacy NV XSWX:RDC 48 Buyback Yield % is -0.01 as of Jun. 27, 2026. GuruFocus rates XSWX:RDC with a GF Score™ of 48/100 and a GF Value™ of CHF143.20 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 271 Healthcare Providers & Services companies, Redcare Pharmacy NV ranks better than 53.14% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Redcare Pharmacy NV's current buyback yield was -0.01%.


Redcare Pharmacy NV Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Redcare Pharmacy NV's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redcare Pharmacy NV Buyback Yield % Chart

Redcare Pharmacy NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Redcare Pharmacy NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.15 -0.16 -0.15 -0.03 -0.03

Redcare Pharmacy NV Buyback Yield % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redcare Pharmacy NV Buyback Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Redcare Pharmacy NV's Buyback Yield % falls into.


XSWX:RDC
48GF Score
Redcare Pharmacy NV XSWX:RDC
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redcare Pharmacy NV Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Redcare Pharmacy NV's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0.373) / 0
=N/A%

Redcare Pharmacy NV's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.187) / 599.3376
=-0.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -0.01 mean?
Redcare Pharmacy NV (XSWX:RDC) has a Buyback Yield % of -0.01 as of Jun. 27, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Redcare Pharmacy NV and its competitors. According to the industry distribution chart, Redcare Pharmacy NV ranks #127 out of 271 companies in the Healthcare Providers & Services industry, placing it in the top 46.9%.
Is Redcare Pharmacy NV's Buyback Yield % too high?
Redcare Pharmacy NV's current Buyback Yield % is -0.01. Based on the distribution chart, Redcare Pharmacy NV ranks #127 out of 271 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Redcare Pharmacy NV has a GF Score™ of 48/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's Buyback Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Redcare Pharmacy NV ranks #127 out of 271 companies for Buyback Yield %. This puts Redcare Pharmacy NV in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Redcare Pharmacy NV and its competitors. Redcare Pharmacy NV's current Buyback Yield % is -0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (XSWX:RDC) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF143.20, compared to a current price of CHF60.95 — trading 57.4% below its estimated fair value. The current Buyback Yield % is -0.01. Redcare Pharmacy NV's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Redcare Pharmacy NV (XSWX:RDC), the current Buyback Yield % is -0.01 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redcare Pharmacy NV (XSWX:RDC) Overvalued in 2026?

Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued. The current stock price of CHF60.95 is trading 57.4% below its estimated GF Value™ of CHF143.20. GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.

Key valuation signals for XSWX:RDC:

  • Buyback Yield %: -0.01
  • GF Value™: CHF143.20 vs. price of CHF60.95 (57.4% below fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the XSWX:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Redcare Pharmacy NV Business Description

Address Erik de Rodeweg 11/13, Sevenum, ZH, NLD, 5975 WD
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
48GF Score

Get the complete analysis for XSWX:RDC

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF60.95
Price
CHF143.20
GF Value